• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视网膜形态对新生血管性年龄相关性黄斑变性患者对比敏感度和阅读能力的影响。

Effects of retinal morphology on contrast sensitivity and reading ability in neovascular age-related macular degeneration.

机构信息

Doheny Image Reading Center, Doheny Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, USA.

出版信息

Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5431-7. doi: 10.1167/iovs.09-4846. Epub 2010 Jun 16.

DOI:10.1167/iovs.09-4846
PMID:20554607
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3061494/
Abstract

PURPOSE

To investigate the effect of changes in retinal morphology on contrast sensitivity and reading ability in patients with neovascular age-related macular degeneration (AMD) in the Avastin (bevacizumab; Genentech, South San Francisco, CA) for choroidal neovascularization (ABC) Trial.

METHODS

Contrast sensitivity obtained with Pelli-Robson charts, reading ability assessed with Minnesota Reading charts, and Early Treatment Diabetic Retinopathy Study (ETDRS) visual acuity (VA) obtained by protocol refraction, were recorded. Raw Stratus optical coherence tomography (OCT; Carl Zeiss Meditec, Inc., Dublin, CA) images were analyzed with the publicly available software OCTOR, which allows precise delineation of any retinal compartment of interest. Thickness and volume were calculated for neurosensory retina, subretinal fluid (SRF), subretinal tissue, and pigment epithelium detachment, and the resulting measurements were correlated with each visual function parameter.

RESULTS

One hundred twenty-two patients with newly diagnosed neovascular AMD and enrolled in the ABC Trial, were evaluated. Increased subretinal tissue volume correlated with decreased contrast sensitivity (Pearson's correlation coefficient, r = -0.4944, P = 0.001). A modest correlation was detected between SRF volume and contrast sensitivity (r = -0.2562, P = 0.004). Increased retinal thickness at the foveal center also correlated with decreased visual function (ETDRS VA: r = -0.4530, P < 0.001).

CONCLUSIONS

The strongest correlation detected between the functional parameters assessed and any of the OCT-derived morphologic parameters was that between decreased contrast sensitivity and increased subretinal tissue. In the future, assessment of contrast sensitivity and reading ability, in combination with quantitative subanalysis of retinal compartments, may lead to the identification of parameters relevant to functional improvement and ultimate prognosis in patients with newly diagnosed neovascular AMD (www.controlled-trials.com number, ISRCTN83325075).

摘要

目的

探讨抗血管内皮生长因子(Avastin,贝伐单抗;基因泰克,旧金山南部,加利福尼亚州)治疗脉络膜新生血管(ABC)试验中新生血管性年龄相关性黄斑变性(AMD)患者视网膜形态变化对对比敏感度和阅读能力的影响。

方法

用 Pelli-Robson 图表记录对比敏感度,用明尼苏达阅读图表记录阅读能力,用协议折射获得早期治疗糖尿病视网膜病变研究(ETDRS)视力(VA)。用公开可用的软件 OCTOR 分析 Stratus 光学相干断层扫描(OCT;卡尔蔡司 Meditec,Inc.,都柏林,加利福尼亚州)的原始图像,该软件允许精确划定任何感兴趣的视网膜区域。计算神经感觉视网膜、视网膜下液(SRF)、视网膜下组织和色素上皮脱离的厚度和体积,并将测量结果与每个视觉功能参数相关联。

结果

评估了新诊断为新生血管性 AMD 并参加 ABC 试验的 122 例患者。视网膜下组织体积增加与对比敏感度降低相关(Pearson 相关系数,r = -0.4944,P = 0.001)。检测到 SRF 体积与对比敏感度之间存在适度相关性(r = -0.2562,P = 0.004)。黄斑中心视网膜厚度增加也与视力下降相关(ETDRS VA:r = -0.4530,P < 0.001)。

结论

在所评估的功能参数与任何 OCT 衍生形态参数之间检测到的最强相关性是对比敏感度降低与视网膜下组织增加之间的相关性。在未来,对比敏感度和阅读能力的评估,结合对视网膜各层的定量亚分析,可能会确定与新诊断的新生血管性 AMD 患者功能改善和最终预后相关的参数(www.controlled-trials.com 编号,ISRCTN83325075)。

相似文献

1
Effects of retinal morphology on contrast sensitivity and reading ability in neovascular age-related macular degeneration.视网膜形态对新生血管性年龄相关性黄斑变性患者对比敏感度和阅读能力的影响。
Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5431-7. doi: 10.1167/iovs.09-4846. Epub 2010 Jun 16.
2
Quantitative comparison of optical coherence tomography after pegaptanib or bevacizumab in neovascular age-related macular degeneration.在新生血管性年龄相关性黄斑变性中,pegaptanib或贝伐单抗治疗后光学相干断层扫描的定量比较。
Ophthalmology. 2008 Feb;115(2):347-354.e2. doi: 10.1016/j.ophtha.2007.03.082. Epub 2007 Jul 12.
3
Quantitative subanalysis of cystoid spaces and outer nuclear layer using optical coherence tomography in age-related macular degeneration.在年龄相关性黄斑变性中使用光学相干断层扫描对囊样间隙和外核层进行定量亚分析。
Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3366-73. doi: 10.1167/iovs.08-2691. Epub 2009 Jan 24.
4
Morphologic parameters relevant for visual outcome during anti-angiogenic therapy of neovascular age-related macular degeneration.与新生血管性年龄相关性黄斑变性抗血管生成治疗期间视觉结局相关的形态学参数。
Ophthalmology. 2014 Jun;121(6):1237-45. doi: 10.1016/j.ophtha.2013.12.029. Epub 2014 Mar 28.
5
Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration.新生血管性年龄相关性黄斑变性中光学相干断层扫描视网膜参数与视力的关系
Ophthalmology. 2008 Dec;115(12):2206-14. doi: 10.1016/j.ophtha.2008.08.016. Epub 2008 Oct 18.
6
Assessment of differential pharmacodynamic effects using optical coherence tomography in neovascular age-related macular degeneration.应用光学相干断层扫描评估新生血管性年龄相关性黄斑变性的药效差异。
Invest Ophthalmol Vis Sci. 2012 Mar 9;53(3):1152-61. doi: 10.1167/iovs.11-8130. Print 2012 Mar.
7
Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.玻璃体内注射贝伐单抗治疗年龄相关性黄斑变性先前治疗过的脉络膜新生血管。
Retina. 2007 Apr-May;27(4):432-8. doi: 10.1097/IAE.0b013e318042b53f.
8
Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.年龄相关性黄斑变性治疗试验比较第二年的黄斑形态与视力
Ophthalmology. 2016 Apr;123(4):865-75. doi: 10.1016/j.ophtha.2015.12.002. Epub 2016 Jan 9.
9
Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.玻璃体内注射贝伐单抗(阿瓦斯汀)治疗新生血管性年龄相关性黄斑变性。
Ophthalmology. 2006 Mar;113(3):363-372.e5. doi: 10.1016/j.ophtha.2005.11.019. Epub 2006 Feb 3.
10
Optical coherence tomography grading reproducibility during the Comparison of Age-related Macular Degeneration Treatments Trials.光学相干断层扫描分级在年龄相关性黄斑变性治疗试验中的重复性比较。
Ophthalmology. 2012 Dec;119(12):2549-57. doi: 10.1016/j.ophtha.2012.06.040. Epub 2012 Aug 28.

引用本文的文献

1
Assessment of optical coherence tomography biomarkers in patients with non-neovascular age-related macular degeneration (AMD) converting to exudative AMD according to the status of the fellow eye.根据对侧眼状况评估非新生血管性年龄相关性黄斑变性(AMD)转变为渗出性AMD患者的光学相干断层扫描生物标志物。
Eye (Lond). 2024 Dec;38(18):3532-3538. doi: 10.1038/s41433-024-03357-x. Epub 2024 Sep 20.
2
Comparative assessment of subretinal hyper-reflective material in patients treated with brolucizumab versus aflibercept in HAWK and HARRIER.比较评估在 HAWK 和 HARRIER 研究中接受 brolucizumab 和 aflibercept 治疗的患者的视网膜下高反射物质。
Br J Ophthalmol. 2024 May 21;108(6):852-858. doi: 10.1136/bjo-2023-323577.
3
Customized designed notch filters and applied effects on glare and contrast sensitivity in patients with dry eye syndrome.定制设计的陷波滤波器及其在干眼症患者的眩光和对比敏感度中的应用效果。
Int Ophthalmol. 2023 Sep;43(9):3309-3319. doi: 10.1007/s10792-023-02735-w. Epub 2023 Jun 17.
4
Impact of intravitreal injection therapy on contrast sensitivity in patients with nAMD and DME.抗 VEGF 治疗对 nAMD 和 DME 患者对比敏感度的影响。
Graefes Arch Clin Exp Ophthalmol. 2023 Jul;261(7):1823-1833. doi: 10.1007/s00417-022-05944-8. Epub 2023 Jan 9.
5
Quantitative assessment of retinal fluid in neovascular age-related macular degeneration under anti-VEGF therapy.抗血管内皮生长因子(VEGF)治疗下新生血管性年龄相关性黄斑变性视网膜积液的定量评估
Ther Adv Ophthalmol. 2022 Mar 23;14:25158414221083363. doi: 10.1177/25158414221083363. eCollection 2022 Jan-Dec.
6
Active Learning of Contrast Sensitivity to Assess Visual Function in Macula-off Retinal Detachment.主动学习对比敏感度以评估黄斑脱离视网膜脱离患者的视觉功能
J Vitreoretin Dis. 2021 Jul 1;5(4):313-320. doi: 10.1177/2474126420961957. Epub 2020 Nov 5.
7
Switching to Brolucizumab in Neovascular Age-Related Macular Degeneration Incompletely Responsive to Ranibizumab or Aflibercept: Real-Life 6 Month Outcomes.在对雷珠单抗或阿柏西普反应不完全的新生血管性年龄相关性黄斑变性中转换为布罗鲁单抗:真实世界6个月的结果
J Clin Med. 2021 Jun 17;10(12):2666. doi: 10.3390/jcm10122666.
8
Baseline Optical Coherence Tomography Parameters That May Influence 6 Months Treatment Outcome of Polypoidal Choroidal Vasculopathy Eyes with Combination Therapy: A Short-Term Pilot Study.基线光学相干断层扫描参数可能影响多灶性脉络膜血管病变眼联合治疗 6 个月的治疗结果:一项短期试点研究。
Int J Environ Res Public Health. 2021 May 18;18(10):5378. doi: 10.3390/ijerph18105378.
9
Visual Parameters and Retinal Morphology for Polypoidal Choroidal Vasculopathy Pre- and Post-Intravitreal Ranibizumab with or without Photodynamic Therapy: A Short-Term Prospective Study.息肉样脉络膜血管病变患者行抗 VEGF 治疗前后的眼底血管参数和视网膜形态变化:一项短期前瞻性研究。
Int J Environ Res Public Health. 2021 Mar 4;18(5):2581. doi: 10.3390/ijerph18052581.
10
Longitudinal Assessment of Ellipsoid Zone Integrity, Subretinal Hyperreflective Material, and Subretinal Pigment Epithelium Disease in Neovascular Age-Related Macular Degeneration.特发性脉络膜新生血管性年龄相关性黄斑变性中椭圆体带完整性、视网膜下高反射物质和视网膜色素上皮病的纵向评估。
Ophthalmol Retina. 2021 Dec;5(12):1204-1213. doi: 10.1016/j.oret.2021.02.012. Epub 2021 Feb 26.

本文引用的文献

1
Acute severe visual decrease after photodynamic therapy with verteporfin: spectral-domain OCT features.维替泊芬光动力治疗后急性严重视力下降:频域光学相干断层扫描特征
Ophthalmic Surg Lasers Imaging. 2010 Nov-Dec;41 Suppl:S85-8. doi: 10.3928/15428877-20101031-10.
2
Accuracy of retinal thickness measurements obtained with Cirrus optical coherence tomography.使用Cirrus光学相干断层扫描获得的视网膜厚度测量的准确性。
Br J Ophthalmol. 2009 Nov;93(11):1461-7. doi: 10.1136/bjo.2008.155846. Epub 2009 Jul 1.
3
Comparison of clinically relevant findings from high-speed fourier-domain and conventional time-domain optical coherence tomography.高速傅里叶域与传统时域光学相干断层扫描临床相关结果的比较
Am J Ophthalmol. 2009 Aug;148(2):242-248.e1. doi: 10.1016/j.ajo.2009.03.004. Epub 2009 May 9.
4
A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study.雷珠单抗玻璃体腔内注射可变剂量方案治疗新生血管性年龄相关性黄斑变性:PrONTO研究的第2年
Am J Ophthalmol. 2009 Jul;148(1):43-58.e1. doi: 10.1016/j.ajo.2009.01.024. Epub 2009 Apr 18.
5
Surrogate markers in clinical trials--challenges and opportunities.临床试验中的替代标志物——挑战与机遇。
Atherosclerosis. 2009 Sep;206(1):8-16. doi: 10.1016/j.atherosclerosis.2008.12.009. Epub 2008 Dec 14.
6
Association between foveal photoreceptor integrity and visual outcome in neovascular age-related macular degeneration.新生血管性年龄相关性黄斑变性中黄斑中心凹光感受器完整性与视觉预后的关系
Am J Ophthalmol. 2009 Jul;148(1):83-9.e1. doi: 10.1016/j.ajo.2009.01.017. Epub 2009 Mar 27.
7
Effect of ranibizumab retreatment frequency on neurosensory retinal volume in neovascular amd.雷珠单抗再治疗频率对新生血管性年龄相关性黄斑变性患者神经感觉层视网膜体积的影响
Retina. 2009 May;29(5):592-600. doi: 10.1097/IAE.0b013e31819b17a5.
8
Evaluation of optical coherence tomography retinal thickness parameters for use in clinical trials for neovascular age-related macular degeneration.用于新生血管性年龄相关性黄斑变性临床试验的光学相干断层扫描视网膜厚度参数评估。
Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3378-85. doi: 10.1167/iovs.08-2728. Epub 2009 Mar 5.
9
Intersession repeatability of contrast sensitivity scores in age-related macular degeneration.年龄相关性黄斑变性患者对比敏感度评分的学期间重复性
Invest Ophthalmol Vis Sci. 2009 Jun;50(6):2621-5. doi: 10.1167/iovs.08-2407. Epub 2009 Feb 14.
10
Photoreceptor status after antivascular endothelial growth factor therapy in exudative age-related macular degeneration.抗血管内皮生长因子治疗渗出性年龄相关性黄斑变性后的光感受器状态
Br J Ophthalmol. 2009 May;93(5):622-6. doi: 10.1136/bjo.2008.151977. Epub 2009 Feb 10.